Q32 Bio Inc. (QTTB)
(Delayed Data from NSDQ)
$45.29 USD
-2.17 (-4.57%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $45.30 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/11/25 |
---|---|
Current Quarter | -1.53 |
EPS Last Quarter | -1.46 |
Last EPS Surprise | -3.55% |
ABR | 1.00 |
Earnings ESP
|
0.66% |
---|---|
Current Year | -5.56 |
Next Year | -5.72 |
EPS (TTM) | -20.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 1.16M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.53 | -1.40 | -5.56 | -5.72 |
# of Estimates | 4 | 2 | 4 | 4 |
Most Recent Consensus | -2.06 | -1.71 | -6.39 | -7.12 |
High Estimate | -0.97 | -1.09 | -4.60 | -4.33 |
Low Estimate | -2.06 | -1.71 | -6.39 | -7.12 |
Year ago EPS | -4.32 | -13.15 | -32.73 | -5.56 |
Year over Year Growth Est. | 64.58% | 89.35% | 83.01% | -2.92% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.53 | -1.40 | -5.56 | -5.72 |
7 Days Ago | -1.45 | -1.24 | -5.31 | -5.41 |
30 Days Ago | -1.24 | -0.77 | -4.94 | -4.84 |
60 Days Ago | -1.24 | -0.77 | -4.94 | -4.84 |
90 Days Ago | -1.11 | -0.77 | -4.41 | -4.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.52 | -1.40 | -5.50 | -5.73 |
Zacks Consensus Estimate | -1.53 | -1.40 | -5.56 | -5.72 |
Earnings ESP | 0.66% | 0.00% | 1.13% | -0.09% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.46 | -1.42 | -13.15 | -4.32 | NA |
Estimate | -1.41 | -1.00 | -1.42 | NA | NA |
Difference | -0.05 | -0.42 | -11.73 | NA | -4.07 |
Surprise | -3.55% | -42.00% | -826.06% | NA | -290.54% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more